Source link : https://www.newshealth.biz/health-news/is-osimertinib-better-alone-or-with-chemotherapy-in-nsclc/
When should patients with advanced or metastatic non–small cell lung cancer receive osimertinib plus platinum-based chemotherapy in the frontline setting and when is osimertinib enough on its own? That is a question brewing among some oncologists now that the US Food and Drug Administration has approved osimertinib (Tagrisso, AstraZeneca) for both indications in patients with […]
Author : News Health
Publish date : 2024-04-23 12:20:05
Copyright for syndicated content belongs to the linked Source.